ADAP(Delisted)
AdaptimmuneยทNASDAQ
--
--(--)
ADAP fundamentals
Adaptimmune (ADAP) released its earnings on Aug 13, 2025: revenue was 13.67M (YoY -89.34%), beat estimates; EPS was -0.02 (YoY -108.33%), beat estimates.
Revenue / YoY
13.67M
-89.34%
EPS / YoY
-0.02
-108.33%
Report date
Aug 13, 2025
EPS
Revenue
Revenue & Expenses
ADAP has released its 2025 Q2 earnings report, with revenue of 13.68M, reflecting a YoY change of -89.33%, and net profit of -30.34M, showing a YoY change of -143.64%. The Sankey diagram below clearly presents ADAP's revenue sources and cost distribution.
Key Indicators
Adaptimmune (ADAP) key financial stats and ratios, covering profitability, financial health, and leverage.
Adaptimmune (ADAP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Adaptimmune (ADAP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Adaptimmune (ADAP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Adaptimmune (ADAP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Adaptimmune (ADAP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
